0000899243-23-011187.txt : 20230412
0000899243-23-011187.hdr.sgml : 20230412
20230412161509
ACCESSION NUMBER: 0000899243-23-011187
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230410
FILED AS OF DATE: 20230412
DATE AS OF CHANGE: 20230412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Armanino Andrew J.
CENTRAL INDEX KEY: 0001807550
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39864
FILM NUMBER: 23815864
MAIL ADDRESS:
STREET 1: C/O CALIFORNIA BANCORP
STREET 2: 1300 CLAY STREET, FIFTH FLOOR
CITY: OAKLAND
STATE: CA
ZIP: 94612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Better Therapeutics, Inc.
CENTRAL INDEX KEY: 0001832415
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 548 MARKET ST. #49404
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94101
BUSINESS PHONE: 415-887-2311
MAIL ADDRESS:
STREET 1: 548 MARKET ST. #49404
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94101
FORMER COMPANY:
FORMER CONFORMED NAME: Mountain Crest Acquisition Corp II
DATE OF NAME CHANGE: 20201116
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-10
0
0001832415
Better Therapeutics, Inc.
BTTX
0001807550
Armanino Andrew J.
C/O BETTER THERAPEUTICS, INC.
548 MARKET STREET, #49404
SAN FRANCISCO
CA
94104
1
0
0
0
0
Common Stock
2023-04-10
4
P
0
303030
0.825
A
454358
I
By Armanino Trust
Common Stock
13334
D
On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share. As one of the PIPE Investors, the Reporting Person acquired 303,030 shares of Issuer common stock on April 10, 2023 for $0.825 per share.
The Reporting Person no longer has a reportable beneficial interest in 15,000 shares of Issuer common stock owned by his son and included in the Reporting Person's prior ownership report on Form 4.
These shares are owned directly by the Andrew J. Armanino III and Denise M. Armanino Family Trust (the "Armanino Trust"), and indirectly by the Reporting Person and his spouse, Denise M. Armanino, as trustees of the Armanino Trust.
/s/ Mark Heinen, Attorney-in-Fact
2023-04-12